Yazan Otoum | Heart Disease | Best Researcher Award

Posted on by Pencis
Education:

Dr. Yazan Otoum holds a Ph.D. in Electrical and Computer Engineering from the University of Ottawa, Canada, where he focused on developing AI-based intrusion detection systems to enhance the security of the Internet of Things (IoT). He earned his M.Sc. in Networks Engineering and Management from DePaul University in the USA in 2009 and a B.Sc. in Software Engineering from Philadelphia University in Jordan in 2006. Dr. Otoum’s diverse educational background equips him with a robust understanding of network security, software development, and emerging technologies, allowing him to contribute significantly to research and teaching in his field.

Professional Experience:

 

Dr. Yazan Otoum is an Assistant Professor of Cybersecurity at Algoma University in Brampton, Ontario, Canada, since 2024. He teaches graduate courses such as Data Structures I, Data Structures II, and Introduction to Cybersecurity. Prior to this, he was a part-time professor at the University of Ottawa and Algonquin College, where he instructed courses in data structures, algorithms, and digital forensics. Dr. Otoum has a solid background in research and teaching, having guided master’s students in developing security frameworks focused on IoT and Federated Learning during his tenure as a Research Assistant at the University of Ottawa. Previously, he was a lecturer at Majmaah University in Saudi Arabia, where he initiated the “Digital Citizenship” project under Saudi Vision 2030, enhancing digital literacy and responsible technology use. His early career included significant roles in system administration for educational projects in Jordan, where he managed platforms serving over 2 million users and led efforts in disaster recovery and cybersecurity analysis.

 

Honours and Awards:

 

Dr. Yazan Otoum has received several accolades for his contributions to cybersecurity education and community engagement. In 2023, he was awarded the Cybersecurity Career Mentor Badge by the EC-Council, recognizing his efforts in mentoring aspiring cybersecurity professionals. He also earned the Cisco Instructor 5 Years of Service Badge in 2019 for his impactful teaching in the Cisco Networking Academy. Notably, in 2018, he received an Award and Certificate of Appreciation from “Saudi Vision 2030” for his role in the “Digital Citizenship” project, which won the best project award. His other recognitions include multiple certificates of appreciation from Majma’ah University for his significant contributions to ABET accreditation, organizing a nationwide robotics competition, and conducting a national cybersecurity boot camp. Additionally, he was acknowledged by the University of Jadara in 2011 for delivering an impactful presentation on eLearning in education.

Graduate Co-Supervision:

Dr. Yazan Otoum has supervised several innovative research projects in the field of cybersecurity and healthcare technology. In 2023, he guided Pratish Pushparaj in developing an Intrusion Detection System Model using LLaMA 2 with generative dataset augmentation. Chaosheng Hu’s project focused on heart disease prediction through federated learning and blockchain integration, while Siddhant Tiwari explored a differential privacy-driven framework for enhancing heart disease prediction. Navya Gottimukkala investigated the application of machine learning in metaverse security. Earlier, in the 2022-2023 academic year, Paritosh Singh worked on deep collaborative learning for robust healthcare security. Dr. Otoum also supervised Yue Wan’s research on a federated transfer learning-based IDS for the Internet of Medical Things (IoMT) and Sai Yadlapalli’s framework for securing IoT through federated transfer learning during the 2020-2021 academic year.

Graduate Courses:

Dr. Yazan Otoum’s teaching portfolio includes advanced topics in cybersecurity, focusing on the integration of machine learning and artificial intelligence for practical applications. He covers wireless ad-hoc networking and the innovative frameworks of software-defined networks (SDN) and cloud computing, which are essential for modern network management. Additionally, his courses explore multimedia communication, emphasizing the importance of secure data transmission in diverse formats. Dr. Otoum also introduces students to deep learning (DL) and reinforcement learning (RL), equipping them with the skills needed to leverage these cutting-edge technologies in cybersecurity.

Conclusion:

Dr. Yazan Otoum’s extensive experience in cybersecurity education, research, and practical applications positions him as a pivotal figure in shaping the next generation of cybersecurity professionals. His commitment to integrating advanced technologies such as machine learning, blockchain, and cloud computing into his curriculum reflects a forward-thinking approach to education. Through his mentorship and innovative teaching methods, Dr. Otoum not only imparts critical knowledge but also inspires students to tackle emerging challenges in the field. His contributions to projects like “Digital Citizenship” under the Saudi Vision 2030 initiative and recognition from prestigious organizations further underscore his dedication to enhancing cybersecurity awareness and education globally. As he continues to lead initiatives and mentor future experts, Dr. Otoum plays a crucial role in advancing cybersecurity practices and fostering a secure digital environment.

Top Notable Publications:

Enhancing Heart Disease Prediction with Federated Learning and Blockchain Integration

Authors: Chaosheng Hu, Yazan Otoum, et al.

Year: 2024

Journal: Future Internet

DOI: 10.3390/fi16100372

Machine Learning in Metaverse Security: Current Solutions and Future Challenges

Authors: Yazan Otoum, et al.

Year: 2024

Journal: ACM Computing Surveys

DOI: 10.1145/3654663

DL-IDS: a deep learning–based intrusion detection framework for securing IoT

Authors: Yazan Otoum, et al.

Year: 2022

Journal: Transactions on Emerging Telecommunications Technologies

DOI: 10.1002/ett.3803

FTLIoT: A Federated Transfer Learning Framework for Securing IoT

Authors: Yazan Otoum, et al.

Year: 2022

Conference: IEEE Global Communications Conference

DOI: 10.1109/GLOBECOM48099.2022.10001461

WOSUID: WOS:000922633501029

Transfer Learning-Driven Intrusion Detection for Internet of Vehicles (IoV)

Authors: Yazan Otoum, et al.

Year: 2022

Conference: International Wireless Communications and Mobile Computing Conference

DOI: 10.1109/IWCMC55113.2022.9825115

WOSUID: WOS:001058917600060

AS-IDS: Anomaly and Signature Based IDS for the Internet of Things

Authors: Yazan Otoum, et al.

Year: 2021

Journal: Journal of Network and Systems Management

DOI: 10.1007/s10922-021-09589-6

On securing IoT from Deep Learning perspective

Authors: Yazan Otoum, et al.

Year: 2021

ISBN: 978-1-7281-8087-8

 

Aristoteles Alencar Neto | Amyloidosis | Excellence in Research

Posted on by Pencis
Dr. Aristoteles Alencar Neto, PMAM, Brazil

Dr. Aristoteles Alencar Neto is a cardiologist from PMAM, Brazil, with specialized training in echocardiography, cardiology, and internal medicine. He completed his medical residency at prestigious institutions such as the Hospital das Clínicas at the University of São Paulo and Santa Casa de Misericórdia de São Paulo. His research focuses on cardiovascular health, including myocardial stiffness and aortic valve treatment, with several publications in leading cardiology conferences. Dr. Alencar is also known for his work in Libman-Sacks endocarditis and antiphospholipid syndrome.

Profile:
Education:

Dr. Aristoteles Alencar Neto is a highly trained cardiologist from Brazil, with a strong educational background in medical residency. He completed his specialization in echocardiography (2018-2020) and cardiology (2016-2018) at the prestigious Hospital das Clínicas, University of São Paulo (FMUSP). Additionally, he specialized in internal medicine (2013-2015) at Santa Casa de Misericórdia de São Paulo. Dr. Alencar Neto earned his medical degree from the Federal University of Amazonas (UFAM) in 2013. His expertise spans cardiology and clinical medicine, with a focus on human health sciences.

Complementary Education:

Dr. Aristoteles Alencar Neto has pursued extensive additional training to enhance his expertise in healthcare management and cardiology. In 2021-2022, he completed an MBA in Administration, specializing in the management of clinics, hospitals, and healthcare industries, from Fundação Getúlio Vargas (FGV). His cardiology-focused training includes advanced courses such as ACLS at FMUSP’s Instituto do Coração, intensive care echocardiography (ECOTIN), and international experience at Hospital Universitário de La Paz in Spain. He has also participated in various continuing education programs to stay current in emergency and cardiovascular care.

Professional Experience:

 

Dr. Aristoteles Alencar Neto has accumulated diverse professional experience in the healthcare field. Since 2020, he has been affiliated with the Instituto do Coração at Hospital das Clínicas (INCOR-FMUSP) in São Paulo, Brazil. He previously worked at Hospital Santa Isabel (2015-2016) and served at the Secretaria Municipal de Saúde de Manaus (SEMSA) from 2009 to 2011. Additionally, Dr. Alencar Neto collaborated with the Federal University of Amazonas (UFAM) between 2008 and 2011, contributing to various healthcare initiatives and research projects.

Research Projects:

Dr. Aristoteles Alencar Neto has participated in various research projects, contributing to advancements in cardiology and related health sciences. His projects have focused on critical topics like heart failure, renal insufficiency in cardiac patients, and advanced imaging techniques in cardiology. His collaborative research has been presented at national and international conferences, helping to enhance clinical practices and patient outcomes in cardiology. Additionally, his work in medical residency programs has been closely tied to academic and clinical research, enriching his contributions to the field of cardiovascular health.

Awards and Titles:

In 2011, Dr. Aristoteles Alencar Neto received an Honorable Mention for his contributions to the Institutional Health Science Research Fellowship Program (PIBIC), recognizing his dedication and excellence in scientific research during his early career in health sciences. This accolade highlights his commitment to advancing medical knowledge through research.

Activities:

Dr. Aristoteles Alencar Neto has been actively involved in several research projects between 2007 and 2011. His work includes contributing to epidemiological studies on tuberculosis and HIV co-infection, investigating hospital morbidity related to tuberculosis in Manaus, and supporting morbid obesity programs. Additionally, he participated in initiatives such as the Neurology and Neurosurgery University League of Amazonas and helped prepare anatomical collections for educational use. His research efforts have significantly contributed to the advancement of public health in the region.

Conclusion:

Dr. Aristoteles Alencar Neto has demonstrated a strong commitment to advancing medical knowledge and public health through his clinical practice, research, and education. With extensive training in cardiology, echocardiography, and internal medicine, coupled with a rich professional and academic background, he has contributed to improving patient care and the understanding of complex medical conditions. His involvement in various research projects and clinical initiatives highlights his dedication to addressing pressing health challenges, particularly in cardiology and infectious diseases, positioning him as a valuable asset to the medical community in Brazil.

Top Notable Publications:

Assessment of Right Ventricular Myocardial Stiffness by Cardiac Elastography in Patients with Transthyretin Amyloidosis

Authors: Not specified in the provided information

Year: 2025

Journal: Current Problems in Cardiology

DOI: 10.1016/j.cpcardiol.2024.102867

Papel da Elastografia por Ondas de Cisalhamento na Avaliação da Rigidez Miocárdica nas Diversas Miocardiopatias

Authors: Not specified in the provided information

Year: 2023

Journal: ABC Imagem Cardiovascular

Date: 2023-12-21

DOI: 10.36660/abcimg.20230108

Role of Shear Wave Elastography in the Assessment of Myocardial Stiffness in Various Cardiomyopathies

Authors: Not specified in the provided information

Year: 2023

Journal: ABC Imagem Cardiovascular

Date: 2023-12-20

DOI: 10.36660/abcimg.20230108i

Tratamiento quirúrgico de la válvula aórtica guiado por ecocardiografía transesofágica 3D en paciente com endocarditis de Libman-Sacks y síndrome antifosfolipídico

Authors: Not specified in the provided information

Year: 2022

Journal: Revista Argentina de Cardiología

DOI: 10.7775/rac.es.v90.i6.20580

Tratamiento quirúrgico de la válvula aórtica guiado por ecocardiografía transesofágica 3D en paciente com endocarditis de Libman-Sacks y síndrome antifosfolipídico

Authors: Not specified in the provided information

Year: 2022

Journal: Revista Argentina de Cardiología

DOI: 10.7775/rac.es.v90.i6.20574

Perfil Clínico, Laboratorial e de Métodos de Imagem na Amiloidose Sistêmica em um Centro de Referência Cardiológico Brasileiro

Authors: Not specified in the provided information

Year: 2021

Journal: Arquivos Brasileiros de Cardiologia

Date: 2021-12-20

DOI: 10.36660/abc.20201003

 

Rachad Zayat | Cardiac Surgery | Best Researcher Award

Posted on by Pencis
Assoc Prof Dr. Rachad Zayat, RWTH University Hospital Aachen, Germany

Assoc. Prof. Dr. Rachad Zayat is a highly skilled and board-certified cardiothoracic surgeon at RWTH University Hospital Aachen, Germany, with over 12 years of operating room experience. Specializing in complex procedures such as coronary artery bypass grafting (CABG), valve repair, pacemaker implantation, and transcatheter aortic valve replacement (TAVR), Dr. Zayat has performed over 450 surgeries in the past two years alone. He is proficient in mechanical circulatory support systems like ECMO and LVAD, and is also known for expertise in minimally invasive and robotic-assisted thoracic surgery. Dr. Zayat is actively involved in academia and medical research, further contributing to advancements in cardiothoracic care.

Profile:
Education:

 

Assoc. Prof. Dr. Rachad Zayat holds a Doctor of Medicine (M.D.) in Cardiac Surgery from RWTH University Hospital, Aachen, Germany, completed in May 2016. His dissertation focused on the impact of percutaneous dilatational tracheostomy on the incidence of sternal wound infections, analyzing a large dataset of 4,100 cases. He earned his German State Examination for Medicine from C.A.U University of Kiel in September 2011, following his high school education at the American College in Aleppo, Syria, where he graduated in August 2003.

Professional Experience:

 

Assoc. Prof. Dr. Rachad Zayat is a highly experienced cardiothoracic surgeon currently serving as Consultant Cardiothoracic Surgeon and Head of the Mechanical Circulatory Support Program at Heart Centre Trier. Since October 2023, he has led groundbreaking procedures, including the first Total Artificial Heart CARMAT® implantation in Rheinland-Pfalz, and developed a successful Robotic Thoracic Surgery program. From 2020 to 2023, he was a Consultant Thoracic Surgeon at RWTH University Hospital Aachen, performing numerous TAVR, CABG, and ECMO procedures while mentoring students and residents. During his cardiac surgery residency (2012-2020), Dr. Zayat gained extensive experience in complex surgeries, including over 100 CABG and 50 valve surgeries.

Research Interest:

 

Assoc. Prof. Dr. Rachad Zayat focuses his research on advancing cardiothoracic surgical techniques, with a particular interest in catheter-based heart valve therapies (TAVR), ultrasound-assisted catheter-directed thrombolysis (EKOS-Lyse) for pulmonary embolism, and mechanical circulatory support systems like ECMO and LVAD. He also explores innovations in heart failure surgery, robotic and minimally invasive thoracic surgery, and works to improve patient outcomes. Dr. Zayat actively engages in medical research, addressing challenges in cardiac surgery, and regularly publishes his findings in peer-reviewed journals.

Conclusion:

In conclusion, Assoc. Prof. Dr. Rachad Zayat stands as a distinguished figure in cardiothoracic surgery, demonstrating exceptional leadership, clinical expertise, and commitment to advancing patient care. His pioneering work in mechanical circulatory support systems, minimally invasive thoracic surgery, and groundbreaking procedures like the first-in-man Total Artificial Heart CARMAT® implantation has solidified his reputation as a leading expert in the field. Dr. Zayat’s contributions to both clinical practice and academic research continue to impact the future of cardiothoracic surgery, inspiring innovation and excellence in the medical community.

Top Notable Publications:

Hima, F., Saunders, A., Kashefi, A., Zayat, R., Kalverkamp, S. (2024). “In vitro evaluation of the performance of an oxygenator depending on the non-standard gas content of the inlet blood with special regard on CO2 elimination.” Perfusion (United Kingdom), 39(8), pp. 1614–1620.
Citations: 0

Schnoering, L., Khattab, M.A., Akhyari, P., Lotfi, S., Zayat, R. (2024). “Pressure-dimension index and left ventricular sphericity index following HeartMate II and HeartMate 3 implantation.” ESC Heart Failure, 11(5), pp. 3012–3022.
Citations: 2

Kolashov, A., Lotfi, S., Spillner, J., Zayat, R., Khattab, M.A. (2024). “Evaluation of myocardial work changes after lung resection—the significance of surgical approach: an echocardiographic comparison between VATS and thoracotomy.” General Thoracic and Cardiovascular Surgery, 72(8), pp. 542–550.
Citations: 0

Billig, S., Zayat, R., Yelenski, S., Hochhausen, N., Derwall, M. (2024). “The Self-Expandable Impella CP (ECP) as a Mechanical Resuscitation Device.” Bioengineering, 11(5), 456.
Citations: 0

Durak, K., Nubbemeyer, K., Zayat, R., Kalverkamp, S., Kersten, A. (2024). “De Ritis Ratio to Predict Clinical Outcomes of Intermediate- and High-Risk Pulmonary Embolisms.” Journal of Clinical Medicine, 13(7), 2104.
Citations: 0

Doukas, P., Dalibor, N., Keszei, A., Akhyari, P., Mehdiani, A. (2024). “Factors Associated with Early Mortality in Acute Type A Aortic Dissection—A Single-Centre Experience.” Journal of Clinical Medicine, 13(4), 1023.
Citations: 0

Abdulwahab, H.A.M., Kolashov, A., Haneya, A., Zayat, R., Khattab, M.A. (2024). “Temperature management in acute type A aortic dissection treatment: deep vs. moderate hypothermic circulatory arrest. Is colder better?” Frontiers in Cardiovascular Medicine, 11, 1447007.
Citations: 0

Hima, F., Kalverkamp, S., Kashefi, A., Spillner, J., Mouzakis, F. (2023). “Oxygenation performance assessment of an artificial lung in different central anatomic configurations.” International Journal of Artificial Organs, 46(5), pp. 295–302.
Citations: 1

Hill, A., Bergmann, D., Schulte, J., Brücken, A., Stoppe, C. (2023). “Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.” Frontiers in Cardiovascular Medicine, 9, 1017867.
Citations: 4

Hill, A., von Dossow, V., Heyland, D.K., Moza, A., Stoppe, C. (2022). “Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device—The PROPER-LVAD Study.” Surgeries (Switzerland), 3(4), pp. 284–296.
Citations: 4

Yu Tian | Cardiac immunology | Best Researcher Award

Posted on by Pencis
Dr. Yu Tian, Jiangsu University, China

Dr. Yu Tian is a prominent researcher at Jiangsu University, China, specializing in immunology and molecular biology. With a focus on immune cell migration, viral myocarditis, and neuroinflammation, Dr. Tian has contributed significantly to understanding immune responses in cardiovascular and neurological diseases. He has published numerous articles in prestigious journals such as Journal of Leukocyte Biology and International Immunopharmacology, and his research explores therapeutic targets like HMGB1 and IL-22. Dr. Tian’s work plays a critical role in advancing treatment strategies for diseases involving immune system dysfunction and inflammation.

Profile:
Education:

 

Dr. Yu Tian completed his Bachelor’s Degree in Medicine at Qinghai University from September 2011 to June 2016. He then pursued his Master’s and Ph.D. at Jiangsu University, School of Medicine, from September 2016 to September 2022, where he specialized in immunology and molecular biology. His academic journey has laid a strong foundation for his research in immune cell function and disease mechanisms, contributing to his current role as a researcher at Jiangsu University.

Professional Experience:

 

Dr. Yu Tian is currently a researcher at Jiangsu University, School of Life Sciences, specifically within the International Genomics Research Center, a position he has held since December 2022. In this role, he leads a horizontal research project investigating the effects of HMGB1 on immune cells, which commenced in 2023. Additionally, Dr. Tian is actively involved in a National Natural Science Foundation of China (NSFC)-funded project that examines the role of IGF-1 in heart damage following myocardial infarction, scheduled for 2025 to 2027. His work contributes significantly to advancing the understanding of immune mechanisms in cardiovascular health.

 

Research Interest:

 

Dr. Yu Tian’s research interests lie in immunology, specifically investigating the role of HMGB1 in immune cell responses. He focuses on cardiovascular diseases, exploring the mechanisms that contribute to heart damage and myocardial infarction. Additionally, Dr. Tian studies adipose tissue accumulation and its impact on worsening heart conditions, aiming to uncover potential therapeutic targets for improving cardiovascular health. His work seeks to enhance the understanding of immune and metabolic interactions in the context of heart disease.

Conclusion:

Dr. Yu Tian is an accomplished researcher at Jiangsu University, specializing in immunology and cardiovascular diseases. With a solid educational background and a focus on the role of HMGB1 in immune responses, he is dedicated to unraveling the complex mechanisms underlying heart damage and myocardial infarction. His ongoing research projects aim to deepen the understanding of immune cell interactions and metabolic factors that exacerbate cardiovascular conditions. Through his contributions, Dr. Tian is poised to make a significant impact on the field, advancing potential therapeutic strategies for improving heart health and addressing related diseases.

Top Notable Publications:

Yin, P., Su, Z., Shu, X., Dong, Z., Tian, Y. (2024). Role of TREM2 in immune and neurological diseases: Structure, function, and implications. International Immunopharmacology, 143, 113286. 0 citations

Tian, Y., Gong, X., Qin, D., Liu, F., Su, Z. (2023). S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. Journal of Leukocyte Biology, 114(2), 154–163. 7 citations

Tian, Y., Chen, R., Su, Z. (2023). HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease. Cellular and Molecular Neurobiology, 43(1), 47–58. 6 citations

Chen, R., Liu, F., Xia, L., Xu, H., Su, Z. (2022). B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. Journal of Leukocyte Biology, 111(2), 415–425. 1 citation

Cao, Y., Tian, Y., Liu, Y., Su, Z. (2022). Reg3β: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. International Reviews of Immunology, 41(2), 160–170. 2 citations

Che, Y., Tian, Y., Chen, R., Liu, F., Su, Z. (2021). IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1867(9), 166171. 26 citations

Chen, W., Yao, S., Wan, J., Yao, Y., Zhang, X. (2021). BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. Journal of Controlled Release, 333, 129–138. 45 citations

Li, J., Xia, L., Liu, F., Chen, R., Su, Z. (2021). lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPβ-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clinical and Translational Medicine, 11(5), e407. 1 citation

Huang, L., Wan, J., Wu, Y., Su, Z., Xu, H. (2021). Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sciences, 270, 119142. 26 citations

Wan, J., Wu, Y., Huang, L., Wang, S., Xu, H. (2021). ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Letters, 502, 34–43. 31 citations

 

 

Chunyan Gao | Thrombosis | Best Researcher Award

Posted on by Pencis
Dr. Chunyan Gao, Harbin Medical University-Daqing, China

Dr. Chunyan Gao is a distinguished medical professional and researcher at Harbin Medical University-Daqing, China. She holds extensive expertise in her field, contributing to medical education and research with a focus on public health and medical sciences. Dr. Gao has published numerous scholarly articles and actively participates in both national and international research collaborations, reflecting her dedication to advancing medical knowledge and improving healthcare outcomes. Her work is particularly recognized for its impact on community health initiatives and academic excellence.

Profile:
Orcid Profile

Education:

Dr. Chunyan Gao completed her Ph.D. at Harbin Medical University, China, from 2010 to 2013, following her M.S. degree from the same university between 2004 and 2007. She earned her B.S. from Jiamusi University, China, in 2001. Dr. Gao’s educational background reflects a strong foundation in medical sciences, contributing to her expertise and research endeavors in the field.

Professional Experience:

Dr. Chunyan Gao has had a distinguished academic career at Harbin Medical University-Daqing, where she has held several key positions since 2001. She began as a Teaching Assistant in the Department of Medical Laboratory Science and Technology from 2001 to 2006, then became a Lecturer from 2006 to 2011. Dr. Gao was promoted to Associate Professor from 2011 to 2015 and has served as a Professor in the same department since 2015. Additionally, she was a Visiting Scholar at the Blood Research Institute, Versiti Wisconsin, in Milwaukee, WI, from 2015 to 2018. Her extensive experience in education and research underscores her commitment to advancing the field of medical laboratory science.

Research and Innovations:

Dr. Chunyan Gao, MD, PhD, is a leading researcher at Harbin Medical University-Daqing, China, focusing on thrombosis and hemostasis. Currently, she serves as the Principal Investigator for several high-profile projects, including a National Natural Science Foundation of China grant (Project No. 82270134, 2023-2026). Dr. Gao has successfully completed various significant projects, such as Project No. 82070140 (2021-2024) and Project No. 81400097 (2015-2017) under the same foundation. Her portfolio also includes the Marshal Initiative Funding (HMUMIF-22005, 2022-2023) and multiple other provincial and institutional grants, showcasing her substantial contributions to advancing research in her field.

Conclusion:

In conclusion, Dr. Chunyan Gao’s extensive research in thrombosis and hemostasis has positioned her as a prominent figure in her field. Through her leadership as Principal Investigator on numerous prestigious projects, including those funded by the National Natural Science Foundation of China and various provincial initiatives, she continues to drive significant advancements in medical science. Her ongoing work not only enhances our understanding of critical health issues but also paves the way for innovative treatments and interventions, reflecting her commitment to improving patient outcomes in the area of vascular health.

Top Notable Publications:

Yan, M., Wang, Z., An, Y., … Wang, D., Gao, C. (2024). OxLDL enhances procoagulant activity of endothelial cells by TMEM16F-mediated phosphatidylserine exposure. Cell Biology International, 48(6), pp. 848–860.

Li, Z., Yan, M., Wang, Z., … Wang, L., Gao, C. (2022). Ferroptosis of Endothelial Cells Triggered by Erythrophagocytosis Contributes to Thrombogenesis in Uremia. Thrombosis and Haemostasis, 123(12), pp. 1116–1128.

Yan, M., Xu, M., Li, Z., … Shi, J., Gao, C. (2022). TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia. Blood Cells, Molecules, and Diseases, 96, 102666.

Yu, H., Wang, Z., Li, Z., … Shi, J., Gao, C. (2021). Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release. FASEB Journal, 35(9), e21808.

Chen, Y., Schroeder, J.A., Gao, C., … Hu, J., Shi, Q. (2021). In vivo enrichment of genetically manipulated platelets for murine hemophilia B gene therapy. Journal of Cellular Physiology, 236(1), pp. 354–365.

Ji, S., Dong, W., Qi, Y., … Shi, J., Gao, C. (2020). Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro. Journal of Thrombosis and Haemostasis, 18(1), pp. 222–233.

Gao, C., Schroeder, J.A., Xue, F., … Czechowicz, A., Shi, Q. (2019). Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice. Blood Advances, 3(18), pp. 2700–2711.

Ma, R., Xie, R., Yu, C., … Zhou, J., Shi, J. (2018). Erratum: Publisher Correction: Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Scientific Reports, 8(1), pp. 6224.

Ma, R., Xie, R., Yu, C., … Zhou, J., Shi, J. (2017). Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Scientific Reports, 7(1), 4978.

Gao, C., Xie, R., Yu, C., … Zhou, J., Shi, J. (2015). Thrombotic role of blood and endothelial cells in uremia through phosphatidylserine exposure and microparticle release. PLoS ONE, 10(11), e0142835.

 

 

Tunç Tunçer | Pediatric Cardiology | Best Researcher Award

Posted on by Pencis
Assist Prof Dr. Tunç Tunçer, Bülent Ecevit University School of Medicine, Turkey

Assoc. Prof. Dr. Tunç Tunçer is a faculty member at the School of Medicine, Bülent Ecevit University, Turkey. He specializes in medical education and research, with a focus on clinical practices. Dr. Tunçer contributes actively to both teaching and research initiatives, working closely with students and colleagues to advance the medical field. His research interests include advancements in medical techniques and patient care, with a dedication to improving healthcare outcomes. Dr. Tunçer is known for his commitment to excellence in education and his role in shaping the next generation of medical professionals.

Profile:
Orcid Profile

Education:

Assist. Prof. Dr. Tunç Tunçer earned his M.D. from Marmara University School of Medicine in 2000. He completed his pediatrics residency in 2005 and further specialized by completing a pediatric cardiology residency in 2014. His advanced training in both pediatrics and pediatric cardiology has equipped him with a strong foundation for his work as a Pediatric Cardiologist.

Professional Experience:

Assist. Prof. Dr. Tunç Tunçer worked as a Pediatric Cardiologist at several Training and Research Hospitals from 2015 to 2022, gaining extensive clinical experience. In 2022, he joined Zonguldak Bülent Ecevit University School of Medicine as an Assistant Professor, where he continues to serve as a Pediatric Cardiologist, contributing to both academic and clinical advancements in pediatric cardiology.

Research Interests:

Assist. Prof. Dr. Tunç Tunçer’s research focuses on critical areas of pediatric cardiology, including the cardiac complications related to COVID-19, advancements in fetal medicine, and the diagnosis and treatment of congenital heart diseases. His work aims to improve understanding and outcomes in these complex and evolving medical fields.

Conclusion:

In summary, Assist. Prof. Dr. Tunç Tunçer is a dedicated Pediatric Cardiologist and Assistant Professor at Zonguldak Bülent Ecevit University School of Medicine. With a solid educational background, extensive professional experience, and active research interests in COVID-19-related cardiac diseases, fetal medicine, and congenital heart diseases, he continues to contribute significantly to both the clinical and academic fields. His work reflects a commitment to improving pediatric healthcare and advancing medical knowledge.

Top Notable Publications:

Cardiovascular Outcomes in Children with Multisystem Inflammatory Syndrome Treated with Therapeutic Plasma Exchange

Authors: Tunçer, T., Varol, F.

Year: 2022

Citations: 3

Efficacy of Extracorporeal Membrane Oxygenation in Pediatric COVID-19 and MIS-C Cases: A Single-Center Experience

Authors: Varol, F., Şahin, E., Kılıç, A., Tunçer, T., Çam, H.

Year: 2022

Citations: 1

Management of Life-Threatening Flecainide Overdose: A Case Report of an Infant

Authors: Tuncer, T.

Year: 2021

Citations: 0

Patterns of Myocardial Involvement During COVID-19 Pandemic; From Newborn to Adolescents

Authors: Tunçer, T., Varol, F., Coşkun, Ş., Güven, Ş., Çam, H.

Year: 2021

Citations: 2

Is There Myocardial Involvement in Children with Long-Term Follow-Up for Kawasaki Disease? A Study Based on Two-Dimensional Speckle Tracking Echocardiography

Authors: Kayabey, Ö., Tuncer, T., Deveci, M., Başar, E.Z., Babaoğlu, K.

Year: 2021

Citations: 1

QT Interval Evaluation Associated with the Use of Hydroxychloroquine with Combined Use of Azithromycin Among Hospitalised Children Positive for Coronavirus Disease 2019

Authors: Tuncer, T., Karaci, M., Boga, A., Durmaz, H., Guven, S.

Year: 2020

Citations: 11

Effects of Atrial Septal Defect Transcatheter Closure on Parameters of Right Ventricular Functions

Authors: Tosun, Ö., Ödemiş, E., Tuncer, V.T., Demir, H.I., Güzeltaş, A.

Year: 2016

Citations: 2

The Evaluation of the Effect of Air Pollution on the Health Status of Children in Zonguldak City, Turkey

Authors: Tecer, L.H., Tomaç, N., Karaca, F., Tunçer, T., Aydin, H.

Year: 2009

Citations: 7

 

 

 

Lívio Pereira de Macêdo | Vitamin D | Best Researcher Award

Posted on by Pencis
Mr. Lívio Pereira de Macêdo, Hospital da Restauração, Brazil

Mr. Lívio Pereira de Macêdo is a dedicated healthcare professional at Hospital da Restauração in Brazil. With a strong commitment to patient care, he has been actively involved in various medical initiatives aimed at improving healthcare delivery and patient outcomes. His expertise encompasses a range of medical practices, and he is known for his collaborative approach, working closely with multidisciplinary teams to enhance the quality of care. Mr. de Macêdo is passionate about advancing healthcare practices and is continually engaged in professional development to stay abreast of the latest medical advancements.

Profile:
Orcid Profile

Education:

Mr. Lívio Pereira de Macêdo is currently pursuing a Master’s degree in Applied Biology to Health at the Universidade Federal de Pernambuco (UFPE), Brazil, under the guidance of Advisor Hildo Rocha Cirne Azevedo-Filho. His research focuses on the impact of Vitamin D on health issues such as ruptured cerebral aneurysms and subarachnoid hemorrhages, within the broader field of Health Sciences and the specialization of Clinical Medicine and Neurology. In addition to his master’s studies, Mr. de Macêdo is undertaking a medical residency in Neurosurgery at Hospital da Restauração, Brazil. He earned his Bachelor’s degree in Medicine from Faculdade Integral Diferencial (FACID) from 2011 to 2016, where he was mentored by Kelson James Silva de Almeida. Mr. de Macêdo’s academic and clinical training positions him as a dedicated professional in the medical field, with a strong emphasis on advancing knowledge in neurology and health sciences.

Professional Development

Mr. Lívio Pereira de Macêdo has pursued a range of complementary educational experiences to enhance his medical expertise. In 2019, he participated in a Microsurgery Anatomy program at the Practical Anatomy and Surgical Education Lab at Saint Louis University (SLU), USA, earning 32 credit hours. His dedication to continuous learning is evident through his involvement in various continuing education programs, including a Cerebrovascular Diseases Study Group at the Federal University of Piauí (UFPI) in 2014, and an Introduction to Clinical Neurology course at the University of California, San Francisco (UCSF) in the same year. Additionally, he has engaged in courses focused on Neuroanatomy, Academic Neurology and Neurosurgery, and Basic Anatomy, further solidifying his foundation in health sciences. Mr. de Macêdo has also enhanced his language skills by completing a Basic English course at Curso de Inglês Prático (CIP) in 2005. These diverse educational experiences reflect his commitment to professional development in the medical field.

Professional Experience:

Mr. Lívio Pereira de Macêdo has gained valuable professional experience at various esteemed institutions in Brazil. Since 2022, he has been a government employee at Hospital da Restauração, contributing significantly to his role with 24 credit hours of service. He also began another government position at the same hospital in 2021, where he has continued to develop his skills and expertise. From 2014 to 2016, he was a scholarship recipient at Fundação Hospitalar de Teresina (FHT), where he dedicated himself exclusively to his role, accumulating 24 credit hours. Earlier, in 2013, he collaborated with FHT for 12 credit hours. In addition to his clinical experience, Mr. de Macêdo served as a Neuroanatomy Monitor at Faculdade Integral Diferencial (FACID) in 2012, accumulating 192 and 108 credit hours in two separate roles, as well as monitoring Anatomy II in 2011 for 161 credit hours. His diverse experiences reflect his commitment to advancing his knowledge and skills in the medical field.

Activities:

Mr. Lívio Pereira de Macêdo has been actively involved in several research projects at Campus I, contributing to important studies in the medical field. Since 2014, he has participated in a research project focused on the Evaluation of Visual Complaints in Patients with Idiopathic Parkinson’s Disease, which aims to enhance understanding of the visual challenges faced by these patients. In 2013, he contributed to a study examining the Rates of Severe Traumatic Brain Injury and Its Relation to Alcoholism in individuals admitted to an emergency hospital following automobile collisions, shedding light on critical public health issues. Additionally, in 2012, Mr. de Macêdo participated in a project investigating the Prevalence of Mycobacterium Tuberculosis Carriers among medical students at a higher education institution in Teresina-PI, addressing the importance of tuberculosis awareness and prevention in educational settings. His involvement in these projects demonstrates his dedication to advancing medical research and improving patient care.

Awards and Titles:

Mr. Lívio Pereira de Macêdo has received notable recognition for his contributions to the field of neurosurgery. In 2021, his work titled “Resection of a Left Insulo-Opercular Cavernoma in a 4-Year-Old Child: A Case Report” was awarded Second Place at the SBNPED Grand Round, held on October 23, 2021. This accolade highlights his dedication to advancing pediatric neurosurgical practices. In 2014, he secured Second Place in the Therapeutic Category at the XXVI Congress of the Ibero-Latin American Society of Diagnostic and Therapeutic Neuroradiology (SILAN), co-hosted by SILAN and SBNR, further underscoring his expertise in the field. Additionally, in 2013, he received an Honorable Mention for Second Place at the 10th Scientific Week of FACID, recognizing his commitment to scientific inquiry and innovation.

Conclusion:

Mr. Lívio Pereira de Macêdo is a dedicated medical professional specializing in neurosurgery, currently affiliated with Hospital da Restauração in Brazil. With a solid educational background, including a Master’s in Applied Biology to Health and ongoing medical residency, he has developed a strong foundation in health sciences and clinical neurology. His practical experience spans various roles in prominent medical institutions, where he has actively participated in research projects focused on neurological disorders and patient care. Lívio’s commitment to excellence has been recognized through multiple awards for his research contributions, reflecting his passion for advancing medical knowledge and improving patient outcomes. As he continues his journey in the medical field, his expertise and dedication are poised to make a significant impact in neurosurgery and beyond.

Top Notable Publications:

Vitamin D Deficiency and Intracranial Aneurysms: Systematic Review
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: World Neurosurgery: X
DOI: 10.1016/j.wnsx.2024.100413

Two Basilar Fenestration Aneurysms Management
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: ACTA Scientific Neurology
ISSN: 2582-1121

A utilização das tecnologias digitais na assistência em saúde
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Revista Eletrônica Acervo Saúde
DOI: 10.25248/reas.e16136.2024
Part of ISSN: 2178-2091

Lesões de pele causadas pelo uso de EPIs durante a pandemia
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Revista Eletrônica Acervo Saúde
DOI: 10.25248/reas.e16134.2024
Part of ISSN: 2178-2091

Middle meningeal artery embolization contraindication when it originates from the ophthalmic artery
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Arquivos de Neuro-Psiquiatria
DOI: 10.1055/s-0044-1786023

The relationship between the level of vitamin D and ruptured intracranial aneurysms among patients with high sun exposure
Authors: Lívio Pereira de Macêdo
Year: 2024
Source: Scientific Reports
DOI: 10.1038/s41598-024-53676-y
Part of ISSN: 2045-2322

Management of a ruptured posterior inferior cerebellar artery (PICA) aneurysm with end-to-end in situ bypass: Case report
Authors: Lívio Pereira de Macêdo
Year: 2023
Source: Journal of Cerebrovascular and Endovascular Neurosurgery
DOI: 10.7461/jcen.2023.e2023.05.006
Part of ISSN: 2287-3139

Vascular changes in patients diagnosed with sepsis: clinical epidemiology and public health aspects
Authors: Lívio Pereira de Macêdo
Year: 2023
Source: Editora IOLE
DOI: 10.5281/ZENODO.10313649

Traumatic spondylolisthesis of the axis without fracture: Case report and literature review
Authors: Lívio Pereira de Macêdo
Year: 2023
Source: Journal of Spine Research and Surgery
DOI: 10.26502/fjsrs0063
Part of ISSN: 2687-8046

Spontaneous anal extrusion of ventriculoperitoneal shunt catheter: Case report
Authors: Lívio Pereira de Macêdo
Year: 2022
Source: Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
DOI: 10.1055/s-0042-1748848
Part of ISSN: 0103-5355, 2359-5922

 

 

Zhitao Li | Food Science | Best Researcher Award

Posted on by Pencis
Dr. Zhitao Li, Jiangnan University, China

Dr. Zhitao Li is a distinguished researcher at Jiangnan University, China. His expertise lies in food science and biotechnology, focusing on areas such as microbial fermentation, enzyme engineering, and food safety. Dr. Li has made significant contributions to the field through his research on fermentation technologies and their applications in food processing. He has authored numerous scientific publications and is recognized for advancing sustainable practices in food production. His work continues to impact both academia and the food industry, promoting innovation in food science.

Profile:
Orcid Profile

Academic Experience:

Dr. Zhitao Li is an Associate Researcher at Jiangnan University, China, where he has been serving since December 2023. Prior to this role, he held positions as a Postdoctoral Researcher and Assistant Researcher at the same university, contributing to advancements in fermentation engineering. Dr. Li earned his Ph.D. in Fermentation Engineering from Jiangnan University in 2021, following a Master’s degree in Animal Nutrition and Feed Science from Hebei University of Engineering in 2016. His research focuses on fermentation technologies, microbial engineering, and their applications in food and feed science.

Research Interests:

Dr. Zhitao Li, an Associate Researcher at Jiangnan University, China, focuses on cutting-edge research in the development and application of bionic digestive organ-on-chip systems. His work also emphasizes green biomanufacturing and the functional evaluation of nutraceuticals and specialized dietary products. Through his innovative research, Dr. Li aims to advance sustainable biomanufacturing technologies and improve the effectiveness of dietary supplements, contributing to both food science and human health.

Awards And Honors:

Dr. Zhitao Li, an Associate Researcher at Jiangnan University, China, has earned numerous accolades for his work in fermentation engineering and innovation. His recognitions include being named a National Excellent Postdoctoral Fellow (2021) and Jiangsu Provincial Excellence Postdoctoral Fellow (2022). He has also been honored with the National Outstanding Innovation and Entrepreneurship Mentor award (2022). Dr. Li has contributed to award-winning projects, including the First Prize in Science and Technology Progress by the China Light Industry Federation (2020) and the Jiangsu Provincial Science and Technology Second Prize (2021). His achievements also include top honors in national innovation and entrepreneurship competitions.

Research Projects:

Dr. Zhitao Li, an Associate Researcher at Jiangnan University, China, is the Principal Investigator of several prestigious research projects. He currently leads a project funded by the National Natural Science Foundation of China (Project No. 32372468, 2024-2027). Dr. Li has also completed two significant projects under the China Postdoctoral Science Foundation, including a Special Grant (2022T150272, 2022-2023) and a General Grant (2021M701463, 2021-2023), where he served as the Principal Investigator. His research continues to make impactful contributions in the fields of fermentation engineering and biomanufacturing.

Conclusion:

Dr. Zhitao Li is a distinguished researcher at Jiangnan University, China, whose work in fermentation engineering, biomanufacturing, and innovative technologies such as bionic digestive organ-on-chip systems has earned him numerous accolades and research grants. With a focus on sustainable practices and advancing the efficacy of nutraceuticals and specialized dietary products, Dr. Li’s contributions continue to push the boundaries of food science and biotechnology. His achievements reflect his leadership and innovation in his field, positioning him as a key figure in both academic and industrial advancements.

Top Notable Publications:

Li, Z.-T. (2023). In Vitro Digestion and Fecal Fermentation of Low-Gluten Rice and Its Effect on the Gut Microbiota. Foods, 12(4), 855. DOI: 10.3390/foods12040855.

Li, Z.-T. (2021). In vitro digestion and fecal fermentation of highly resistant starch rice and its effect on the gut microbiota. Food Chemistry, 358, 130095. DOI: 10.1016/j.foodchem.2021.130095.

 

 

Continue reading “Zhitao Li | Food Science | Best Researcher Award” →

Guido Sireci | Recent Advancements | Lifetime achievement Award

Posted on by Pencis
Assoc Prof Dr. Guido Sireci, BIND Università di Palermo, Italy

Assoc. Prof. Dr. Guido Sireci is an Associate Professor at the Department of Biological, Chemical, and Pharmaceutical Sciences and Technologies (BIND) at the Università di Palermo, Italy. His research focuses on immunology, particularly in understanding immune responses in infectious diseases and cancer. Dr. Sireci has contributed to numerous scientific publications and actively collaborates in both national and international research projects, advancing the field of biomedical sciences. He is recognized for his expertise in cellular immunology and the development of novel therapeutic approaches.

Profile:
Scopus Profile 

Education Qualification:

Assoc. Prof. Dr. Guido Sireci graduated from the Liceo Classico “G. Garibaldi” in Palermo in 1975 with a diploma in Classical Studies. He earned his degree in Biological Sciences from the University of Palermo in 1982, achieving a final grade of 105/110. In the same year, he obtained professional certification as a Biologist with the highest grade. Dr. Sireci began his specialization in General Pathology (now Clinical Pathology) at the University of Palermo in 1984 and completed it in 1987, graduating with a top grade of 50/50. His specialization thesis focused on the “Immunosuppressive Effects of Cyclosporine A.”

Teaching Activities:

Assoc. Prof. Dr. Guido Sireci has been engaged in academia at the University of Palermo since 1985, conducting theoretical and practical exercises in laboratory techniques, molecular biology, and immunology for students in the General Pathology and Genetics courses. From 1987 to 1989, he served as a lecturer in Immunology and General Pathology at the School of Professional Nursing, as well as lecturing in General Pathology at the Physiotherapy School and Chemistry at the Nursing School at Villa Sofia Hospital. He taught Immunopathology at the Faculty of Pharmacy from 1998 to 2000 and covered General Pathophysiology, General Pathology, and Immunology in the Nursing Diploma program in 1999. Since 2002, Dr. Sireci has been a lecturer in Immunology at the Faculty of Medicine and Surgery in Caltanissetta, and since 2010, he has taught General Pathology for the Nursing Science degree program at the Policlinico of Palermo.

Awards:

In 1999, Assoc. Prof. Dr. Guido Sireci was honored with the “Best Abstract Award” at the EFI Congress held in Montpellier, recognizing his significant contributions to the field of immunology. This accolade highlights his commitment to advancing research and knowledge within the scientific community.

Scientific Career:

Assoc. Prof. Dr. Guido Sireci has an extensive academic and research background. From 1985 to 1986, he specialized as a resident at the Institute of General Pathology (now the Department of Biopathology and Biomedical Methodologies) at the University of Palermo. In 1986, he was contracted as a Senior Technician at the Department of Immunobiology, Wellcome Research Laboratories, in London. He received a research grant from the Regional Health Department from 1987 to 1989 and was appointed as a Technical Officer at the Institute of General Pathology in 1990 after winning a public competition. Dr. Sireci was awarded a C.N.R. (National Research Council) scholarship in 1996 as a Visiting Scientist at the Transplantation Biology Group, Royal Postgraduate Medical School, Hammersmith Hospital, London. In 2001, he qualified for the position of Associate Professor at the Faculty of Medicine and Surgery at the University of Catania.

Conclusion:

Assoc. Prof. Dr. Guido Sireci is a distinguished academic and researcher in the field of General Pathology and Immunology. With a career spanning several decades, he has contributed significantly to both education and research, holding various positions at prestigious institutions such as the University of Palermo and Wellcome Research Laboratories in London. His expertise encompasses laboratory techniques, molecular biology, and immunological applications in experimental medicine. Dr. Sireci’s dedication to advancing knowledge in his field is evidenced by his numerous teaching roles, research grants, and recognition, including the “Best Abstract Award” at the EFI Congress. His ongoing commitment to education and research continues to impact future generations of medical professionals and scientists.

Top Notable Publications:

Maccora, S., Bolognini, N., Mannina, C., Sireci, G., Brighina, F.
The effects of estradiol levels on crossmodal perception: a study on the sound-induced flash illusion in healthy and menstrually related migraine individuals
Neurological Sciences, 2023, 44(8), pp. 2863–2870.
Citations: 0

Guggino, G., La Manna, M.P., Di Liberto, D., Sireci, G., Ciccia, F.
Interleukin 9 neutralisation reduces collagen-induced arthritis severity in mouse models
Clinical and Experimental Rheumatology, 2023, 41(1), pp. 94–102.
Citations: 5

Artigas-Jerónimo, S., González-García, A., de la Fuente, J., Torina, A., Sireci, G.
Low NETosis Induced in Anaplasma phagocytophilum-Infected Cells
Vaccines, 2022, 10(10), 1756.
Citations: 1

Mohammadnezhad, L., Shekarkar Azgomi, M., La Manna, M.P., Guggino, G., Caccamo, N., Sireci, G.
Metabolic Reprogramming of Innate Immune Cells as a Possible Source of New Therapeutic Approaches in Autoimmunity
Cells, 2022, 11(10), 1663.
Citations: 10

Maggio, M.C., Failla, M.C., Giordano, S., Manna, M.P.L., Sireci, G.
Interleukin-6 Is a Promising Marker of COVID-19 in Children: A Case Series of 2 Brothers with Severe COVID-19 Pneumonia
American Journal of Case Reports, 2022, 23, e934468.
Citations: 3

Sireci, G., Badami, G.D., Di Liberto, D., de la Fuente, J., Torina, A.
Recent Advances on the Innate Immune Response to Coxiella burnetii
Frontiers in Cellular and Infection Microbiology, 2021, 11, 754455.
Citations: 16

de la Fuente, J., Armas, O., Sánchez-Rodríguez, L., Nova, R., Queirós, J., Sireci, G.
Citizen science initiative points at childhood BCG vaccination as a risk factor for COVID-19
Transboundary and Emerging Diseases, 2021, 68(6), pp. 3114–3119.
Citations: 9

Di Liberto, D., Scazzone, C., La Rocca, G., Guggino, G., Sireci, G.
Erratum: Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis
Clinical and Experimental Rheumatology, 2020, 38(6), pp. 1276.
Citations: 3

Torina, A., Blanda, V., Villari, S., de la Fuente, J., Sireci, G.
Immune response to tick-borne hemoparasites: Host adaptive immune response mechanisms as potential targets for therapies and vaccines
International Journal of Molecular Sciences, 2020, 21(22), pp. 1–22, 8813.
Citations: 13

Guggino, G., Schinocca, C., Lo Pizzo, M., Sarzi-Puttini, P., Dieli, F., Sireci, G.
Erratum: T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy
Clinical and Experimental Rheumatology, 2020, 38(6), pp. 1275.
Citations: 3

 

Stephane Manzo-Silberman | Cardiology | Best Researcher Award

Posted on by Pencis

Dr.Stephane Manzo-Silberman | Cardiology | Best Researcher Award 

 Dr. Stephane Manzo-Silberman, APHP Sorbonne University, France

Dr. Stephane Manzo-Silberman is a renowned cardiologist at Assistance Publique-Hôpitaux de Paris (APHP) and a faculty member at Sorbonne University, France. She specializes in cardiovascular diseases, with a focus on coronary artery disease and interventions. Dr. Manzo-Silberman is actively involved in clinical research, particularly in the fields of interventional cardiology and thrombosis, and she has contributed extensively to academic publications in these areas. In addition to her clinical work, she plays a key role in advancing medical education and promoting innovative cardiovascular therapies.

Profile:

Scopus Profile 

 

Education Qualification:

Dr. Stéphane Manzo-Silberman, MD, MSc, completed her medical and clinical training in cardiology at René Descartes University, Paris, where she earned her Doctorate in Medical Sciences (2005) and specialized in cardiology. She also holds a Master’s degree in Biological Sciences (2004). Her clinical expertise was further developed during her residency in internal medicine and cardiology (2000-2005), followed by advanced training as a senior resident in interventional cardiology at Cochin Hospital (2006-2011) and in coronary angiography and angioplasty at Clinique Pasteur, Toulouse (2006), under the mentorship of Pr. J Marco and Dr. J Fajadet.

Current Position:

Dr. Stéphane Manzo-Silberman currently serves as Senior Consultant at the Cardiac Catheterization Laboratory and Coronary Care Unit of the Cardiology Institute at Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris. In this role, she specializes in interventional cardiology, managing complex cardiac procedures and providing advanced care for patients with coronary artery disease. Her position reflects her expertise in cardiovascular interventions and her dedication to improving clinical outcomes in cardiology.

Awards:

Dr. Stéphane Manzo-Silberman has received several prestigious awards throughout her career, including the French Society of Cardiology Prize for the best doctorate dissertation (2005) and the French Society of Angeology Junior Prize for the best master’s dissertation (2005). She was also honored with the Young Investigator Prize at JESFC 2017 and received an ESC Grant in 2020 to attend the Women Transforming Leadership Programme, highlighting her continued excellence in cardiology and leadership development.

Research Experience:

Dr. Stéphane Manzo-Silberman serves as the principal investigator in numerous multicenter academic clinical research studies. Her work includes leading pivotal studies such as the DOLORES registry, the DeFSSICA survey on acute heart failure management, and the First French Metaregistry on gender differences in myocardial infarction. She has also co-authored the EAPCI Women’s Survey on radiation protection in catheterization labs and chaired an EAPCI position statement on radiation protection during pregnancy for healthcare professionals. Additionally, she oversees major national projects like the WAMIF study on acute myocardial infarction in young women and the ACFA study on atrial fibrillation care pathways. Dr. Manzo-Silberman also actively directs theses and dissertations, mentoring the next generation of cardiology professionals.

Conclusion:

Dr. Stéphane Manzo-Silberman stands as a prominent figure in the field of cardiology, reflecting a deep commitment to advancing cardiovascular health and understanding. His extensive research, focused on the intricate dynamics of heart disease, particularly among diverse populations, underscores the critical importance of tailored medical approaches. Through his leadership in various studies and initiatives, Dr. Manzo-Silberman not only contributes to the scientific community but also advocates for improved patient outcomes and health equity. As he continues to explore new frontiers in cardiology, his work promises to inspire future generations of medical professionals and researchers, paving the way for innovative solutions to the challenges faced in cardiovascular care.

Top Notable Publications:

Laghlam, D., Benghanem, S., Ortuno, S., Hamzaoui, O., & Aissaoui, N. (2024). Management of cardiogenic shock: A narrative review. Annals of Intensive Care, 14(1), 45.

Sabouret, P., Barbato, E., Montalescot, G., Biondi-Zoccai, G., & Manzo-Silberman, S. (2024). Remembering our friend Jean-Philippe Collet: A giant in cardiology, a gentleman in life. Minerva Cardiology and Angiology, 72(4), 329-331.

Manzo-Silberman, S., Martin, A.-C., Boissier, F., Puymirat, E., & Delmas, C. (2024). Sex disparities in cardiogenic shock: Insights from the FRENSHOCK registry. Journal of Critical Care, 82, 154785.

Manzo-Silberman, S., Guedeney, P., Cayla, G., Montalescot, G., & Silvain, J. (2024). Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients with Chronic Coronary Syndrome. JACC: Cardiovascular Interventions, 17(12), 1413-1421.

Manzo-Silberman, S., Montalescot, G., & Lebreton, G. (2024). Has DanGer-Shock reshuffled the cards for mechanical circulatory support trials? Archives of Cardiovascular Diseases (Article in Press).

Hebbo, E., Khan, S., Manzo-Silberman, S., & Alasnag, M. (2024). The Clinical Approach to Angina in Women. Interventional Cardiology Clinics (Article in Press).

Manzo-Silberman, S., & Montalescot, G. (2023). Benefits of an observatory for myocardial infarction in women under 50: The WAMIF study. Annales de Cardiologie et d’Angeiologie, 72(6), 101691.

Manzo-Silberman, S., Chouihed, T., Ticelli, L.F., Roubille, F., & El Khoury, C. (2023). Assessment of atrial fibrillation in European emergency departments: Insights from a prospective observational multicenter study. Minerva Cardiology and Angiology, 74(4), 444-455.

Weizman, O., Tea, V., Marijon, E., Simon, T., & Danchin, N. (2023). Very long-term outcomes after acute myocardial infarction in young men and women: Insights from the FAST-MI program. Archives of Cardiovascular Diseases, 116(6-7), 324-334.

Sabouret, P., Manzo-Silberman, S., Alasnag, M., Biondi-Zoccai, G., & Bhatt, D.L. (2023). New approaches to reduce recurrent PCI: To angioplasty and beyond! European Heart Journal Open, 3(3), oead049.